BR-cadherin, designated as cadherin 12 (CDH12) within the molecular lexicon of human genetics, emerges as a quintessential component of the cadherin superfamily, specializing in cell adhesion. This protein is intricately involved in orchestrating cell-cell communication, pivotal for maintaining the architectural and functional cohesion within tissues, particularly in the nervous system where its expression is predominantly observed. BR-cadherin's role in neural development is underscored by its involvement in the modulation of neuronal positioning and the establishment of complex neural networks. The protein's structural design, inclusive of extracellular cadherin repeats conducive to calcium-dependent adhesion, facilitates homophilic interactions between cells. These interactions are crucial for the developmental processes that necessitate precise cell positioning and the formation of orderly tissue structures. Moreover, BR-cadherin's interaction with the cytoskeleton through its cytoplasmic domain not only stabilizes cell-cell adhesion but also transduces signals that are essential for cell behavior and fate determination.
The activation mechanisms of BR-cadherin are multifaceted, reflecting the complexity of cellular signaling and the pivotal role of cadherins in mediating dynamic cell responses to external cues. Activation can be driven by the upregulation of BR-cadherin expression, enhancing the protein's availability for cell-cell adhesion and signaling interactions. This upregulation is often a result of transcriptional control mechanisms responsive to developmental signals or cellular environments that dictate tissue patterning and integrity. Post-translational modifications, such as phosphorylation, can further modulate BR-cadherin's activity, affecting its affinity for binding partners and its ability to convey signals. The interaction between BR-cadherin and cytoplasmic proteins, such as catenins, is another critical aspect of its activation, facilitating the linkage to the actin cytoskeleton and the transmission of signals that regulate cell polarity, migration, and proliferation. Importantly, the extracellular calcium concentration, by stabilizing the cadherin structure, ensures the adhesive function of BR-cadherin is appropriately modulated in response to cellular and environmental contexts, enabling cells to adapt their adhesion and signaling in a dynamic manner. Through these mechanisms, BR-cadherin plays a fundamental role in coordinating cellular processes that are essential for tissue development, maintenance, and regeneration, highlighting its significance in the broader spectrum of cellular function and organismal health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride (LiCl) is a salt that has been shown to activate BR-cadherin expression in a variety of cell types. LiCl can activate BR-cadherin by inhibiting the GSK3β kinase, which is a negative regulator of BR-cadherin expression. GSK3β is a serine/threonine kinase that plays a role in a variety of cellular processes, including cell signaling, cell growth, and apoptosis. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is a diterpene that has been shown to activate BR-cadherin expression in a variety of cell types. Forskolin can activate BR-cadherin by increasing the levels of cyclic AMP (cAMP), which is a second messenger that can activate a variety of signaling pathways, including the BR-cadherin activation pathway. cAMP is a signaling molecule that is produced in response to a variety of stimuli, including hormones, neurotransmitters, and growth factors. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a serine/threonine kinase inhibitor that has been shown to activate BR-cadherin expression in a variety of cell types. Staurosporine can activate BR-cadherin by inhibiting the PKC kinase, which is a negative regulator of BR-cadherin expression. PKC is a serine/threonine kinase that plays a role in a variety of cellular processes, including cell signaling, cell growth, and differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is a mammalian target of rapamycin (mTOR) inhibitor that has been shown to activate BR-cadherin expression in a variety of cell types. Rapamycin can activate BR-cadherin by inhibiting the mTOR signaling pathway, which can lead to the activation of the AMPK signaling pathway, which in turn activates BR-cadherin. The mTOR signaling pathway is a major regulator of cell growth, proliferation, and metabolism. | ||||||